X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Animal Model Companies

This report lists the top Animal Model companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Animal Model industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Animal Model Top Companies

  1. Genoway

  2. Labcorp UK Limited (Envigo Rms Inc.)

  3. Janvier Labs

  4. Biocytogen Pharmaceuticals Co., Ltd.

  5. Harbour BioMed Co.

*Disclaimer: Top companies sorted in no particular order

 Animal Model Market Major Players

Animal Model Market Concentration

Animal Model Market Concentration

Animal Model Company List

                              • Biocytogen Pharmaceuticals Co. Ltd

                              • Charles River Laboratories International Inc.

                              • Labcorp UK Limited (Envigo Rms Inc.)

                              • Genoway

                              • Harbour BioMed Co. Ltd

                              • Hera Testing Laboratories Inc.

                              • Janvier Labs

                              • Taconic Biosciences Inc.

                              • The Jackson Laboratory

                              • Trans Genic Inc.

                              • JSR Corporation

                              • Ozgene Holdings Pty Ltd

                              • PerkinElmer Inc. (Horizon Discovery Group PLC)


                          Specific to Animal Model Market
                          Need More Details On Market Players And Competitors?
                          Download PDF

                          Animal Model Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)